← FDA Drug Approvals (Drugs@FDA)

MICAFUNGIN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2021-07-09

Drug application

FDA Application #
ANDA213261
Application type
Abbreviated New Drug Application (Generic)
Brand name
MICAFUNGIN SODIUM
Generic name
MICAFUNGIN SODIUM
Active ingredients
MICAFUNGIN SODIUM
Dosage form
INJECTABLE
Route
INTRAVENOUS
Marketing status
Prescription
Sponsor
HIKMA
Manufacturer
Hikma Pharmaceuticals USA Inc.
First approval
2021-07-09

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown